CBD for Dogs UK

If you have searched for CBD for your dog in the last year, you have probably come across two completely contradictory impressions. The first is that CBD is a gentle, natural wellbeing supplement that thousands of UK owners give their dogs every day. The second is that it is a controlled, prescription-only substance you cannot legally buy for a pet at all.

Both impressions come from something real, and the gap between them is where most UK owners get lost. This guide closes that gap. It sets out exactly what UK law says, what the veterinary research has and has not demonstrated, and what your realistic options are if your dog is struggling.

The short answer

In the UK, any CBD product intended for use in animals is legally classed as a veterinary medicine. It therefore requires a marketing authorisation before it can be sold or supplied, and no CBD product has ever been granted one for veterinary use in this country. There is no legal over-the-counter CBD product for dogs in the UK. The only lawful route is a prescription written by your own vet under the veterinary prescribing cascade.


That is the position. The rest of this guide explains how it came about, why CBD dog products are nonetheless easy to find online, and what the underlying science actually supports, which is a good deal less than the marketing usually implies and a good deal more than nothing.

First, what CBD actually is

Cannabidiol, usually shortened to CBD, is one of more than a hundred cannabinoid compounds produced by the plant Cannabis sativa. It is not intoxicating. Unlike THC, the compound responsible for the psychoactive effects of cannabis, CBD binds only weakly to the CB1 receptor in the brain, so it does not produce a high in dogs or in people.

That distinction matters enormously for dogs, because THC is genuinely toxic to them. Dogs have a far higher density of cannabinoid receptors in the hindbrain than humans do, which is why THC exposure in dogs tends to produce more severe neurological signs than the equivalent exposure in a person. Any product intended for a dog that carries a meaningful THC content is a safety problem, not a wellbeing product.

CBD oil and hemp oil are not the same thing

This is the single most common confusion in the category, and a lot of packaging does nothing to clear it up.

  • Hemp seed oil is cold-pressed from the seeds of the hemp plant. It is a source of fat and essential fatty acids, contains only trace cannabinoids, and is a permitted feed material. You will find it in plenty of ordinary dog foods and supplements.

  • CBD oil is an extract of the flower and leaf, where the cannabinoids are concentrated. It is deliberately formulated to deliver cannabidiol, and it is this that UK regulators treat as a medicine.

If a UK dog product markets itself around the word "hemp" but the ingredients list shows hemp seed oil and nothing more, it contains essentially no CBD. That is not necessarily a bad product. It is simply not a CBD product, whatever the packaging implies.

The UK legal position

The 2018 VMD ruling

In September 2018 the Veterinary Medicines Directorate, the executive agency of Defra responsible for regulating animal medicines in the UK, published a formal statement on CBD. Its conclusion was that veterinary products containing cannabidiol are veterinary medicines and should be regulated as such.

The reasoning was specific. The Veterinary Medicines Regulations define a veterinary medicine as any substance that may be administered to animals with a view to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action, or to making a medical diagnosis. The VMD determined that CBD meets that definition by virtue of the effects it has. In other words, CBD was classified as a medicine precisely because it does something pharmacologically, not despite it.

The immediate consequence is that CBD products for animals require a marketing authorisation before they can be sold or supplied in the UK. As of the date of this article, no CBD-based product has ever been granted a UK veterinary marketing authorisation. Not one.

What that means in practice

1. Selling or supplying a CBD product for use in dogs, without a marketing authorisation, is not permitted. The VMD stated at the time that it would be writing to UK CBD suppliers and manufacturers to inform them of the decision.

2. Companies selling CBD lawfully for human use are explicitly not permitted to indicate or recommend those products for use on animals. A human CBD oil that carries dosing guidance for dogs on its label or website is outside the rules.

3. Administering an unauthorised CBD product to an animal without a veterinary prescription is an offence under Regulation 8 of the Veterinary Medicines Regulations. This is the part most owners are unaware of. The restriction is not only on the seller. It reaches the act of giving it to the dog.

The one legal route: the prescribing cascade

British vets have a legal mechanism, known as the cascade, for treating an animal when no authorised veterinary product exists for the condition in question. It allows a vet, exercising their clinical judgement and under their own responsibility, to prescribe alternatives in a defined order of preference, including human medicines.

Because there is no authorised veterinary CBD product, the VMD confirmed that a vet may prescribe a legally obtained human CBD product under the cascade. That is the only route by which a UK dog can lawfully receive CBD.

It is worth setting expectations honestly here. Many UK vets will decline, and they have defensible reasons: the clinical evidence base in dogs is thin, product quality across the human CBD market is inconsistent, and the vet carries personal professional responsibility for the outcome. A refusal is not obstruction. It is a clinician declining to prescribe something they cannot yet stand behind.

So why can I still buy CBD dog treats online?

Because enforcement in this category is limited and the market is large, fragmented and heavily cross-border. Products reach UK consumers through overseas sellers, marketplace listings, and domestic brands that describe their products in deliberately vague terms to avoid stating an animal indication outright.

The existence of a product on a website is not evidence of its legal status. It is evidence that no one has yet stopped it. Separately, industry bodies have been lobbying Defra and the VMD to revisit the 2018 position and open a regulated pathway for animal wellbeing products containing CBD. At the time of writing, the 2018 statement remains the operative UK position and has not been superseded.

What the research actually shows

Set the law aside for a moment. Even in jurisdictions where owners can buy CBD freely, the honest scientific picture is more modest than the category's marketing suggests. Here is what the peer-reviewed canine literature supports, and what it doesn't.

Joint comfort and mobility: the strongest signal

This is where the canine evidence is most encouraging. A 2018 Cornell University study, published in Frontiers in Veterinary Science, ran a randomised, placebo-controlled, blinded crossover trial in dogs with osteoarthritis. Dogs received CBD-enriched oil at 2 mg/kg twice daily for four weeks, with a two-week washout between arms. Owner-scored pain measures fell and activity scores rose significantly on CBD compared with placebo.

A 2021 pilot study published in the Journal of the American Animal Hospital Association looked at the same question in naturally occurring osteoarthritis and added to the picture, though as a pilot its conclusions are necessarily preliminary.

The caveats are real. These are small studies, typically involving twenty to forty dogs, running for weeks rather than months, and frequently funded by the companies producing the CBD used. That does not make the findings wrong. It does mean they are a starting point, not a settled conclusion.

Anxiety and noise fear: genuinely mixed, and mostly disappointing

This is the use case owners ask about most, and it is the one where the evidence is weakest. It deserves stating plainly, because a great deal of marketing implies otherwise.

A 2020 University of Kentucky study tested CBD treats in sixteen noise-reactive dogs using a validated fireworks-based fear model, with trazodone as an active comparator. At a dose of 1.4 mg/kg per day, CBD did not reduce plasma cortisol, did not reduce the duration of inactivity, and did not alter tail posture. The trazodone comparator did lower cortisol; CBD did not. The authors' conclusion was that their results do not support an anxiolytic effect of CBD in dogs at that dose.

A 2023 study from the Waltham Petcare Science Institute pointed the other way, finding that a single dose of CBD positively influenced several measures of stress in dogs during separation and car travel. The obvious difference is design: acute, single-dose exposure to a defined stressor, rather than repeated dosing against noise phobia.

Read together, the fair summary is that CBD may help some dogs with acute, short-lived, predictable stressors, and there is no good evidence yet that it addresses established noise phobia or chronic anxiety at the doses tested. Anyone telling you the anxiety case is proven has not read the anxiety literature.

Seizures: promising, small, and widely overstated

A 2019 randomised, blinded, controlled trial at Colorado State University, published in the Journal of the American Veterinary Medical Association, added oral CBD at 2.5 mg/kg twice daily for twelve weeks to conventional antiepileptic treatment in dogs with intractable idiopathic epilepsy.

The CBD group showed a statistically significant reduction in seizure frequency, with a median change of 33 per cent, compared with placebo. But the proportion of dogs meeting the conventional definition of a treatment responder, a reduction of at least 50 per cent in seizure activity, was not significantly different between the groups. The authors themselves flagged this as arguably the more clinically meaningful measure. Two dogs in the CBD group developed ataxia and were withdrawn. The study was funded by the company that produced the oil, and the lead author held a five per cent ownership stake in it.

That is a study worth taking seriously and a study worth reading carefully. Headlines describing it as proof that CBD controls canine epilepsy do not survive contact with the actual results.

Safety: what the studies consistently flagged

Across the canine literature, CBD has generally been well tolerated in the short term. That is not the same as harmless, and several findings recur often enough to take seriously.

  • Raised liver enzymes. A significant rise in serum alkaline phosphatase (ALP) appeared in both the Cornell osteoarthritis trial and the Colorado State epilepsy trial. Whether this reflects an adaptive response or early liver stress is not yet settled, which is exactly why it warrants monitoring rather than dismissal.

  • Ataxia. Wobbliness and loss of coordination caused two dogs to be withdrawn from the epilepsy trial. It is dose-related and reversible, but it is a real effect.

  • Gastrointestinal upset. Vomiting, soft stools and diarrhoea appear across the safety literature, generally at higher doses.

  • Drug interactions. This is the underappreciated risk. CBD inhibits cytochrome P450 enzymes, the liver's main drug-metabolising system. The Kentucky study provides a concrete illustration: CBD appeared to blunt trazodone's effect on cortisol, consistent with interference in trazodone's metabolism. If your dog takes anything regularly, this is not a theoretical concern.

There is also a quality problem specific to an unregulated market. Independent testing of CBD pet products in markets where they are sold openly has repeatedly found label claims that do not match contents, including products with substantially less CBD than stated and, more worryingly, detectable THC. Human CBD products carry an additional hazard: some contain xylitol as a sweetener, which is severely toxic to dogs even in small amounts.

If your dog is struggling, what should you actually do?

Start with the diagnosis, not the product. Stiffness on rising, reluctance on stairs, a shortened stride or a change in temperament are signals, and they have causes. Osteoarthritis, hip dysplasia, cruciate disease, spinal pain and dental pain can all present as a dog who is simply slowing down. Reaching for an analgesic of any kind, including CBD, before you know what you are treating risks masking something that needs proper management.

Book the vet appointment. Ask directly about CBD if you want to; a good vet will not be offended by the question and will explain their reasoning either way. If they judge it appropriate, the cascade gives them a lawful route. If they decline, ask what they would do instead, because the answer will usually involve options with considerably better evidence behind them: weight management, structured low-impact exercise, physiotherapy or hydrotherapy, environmental changes such as ramps and non-slip flooring, and licensed veterinary analgesics.

Where nutritional supplements sit, and where they do not

Complementary feeds are a separate legal category from veterinary medicines. They are regulated as feed rather than as medicine, they are not permitted to make medicinal claims, and they are not licensed to treat a diagnosed condition. Joint supplements, calming formulations and skin and coat products all sit here.

It is worth being straightforward about what that means. A complementary feed is not a substitute for CBD, and it is not a substitute for veterinary treatment. It is a different kind of thing doing a different kind of job, as part of a broader routine for a healthy dog. Anyone who presents a supplement as the legal workaround for a medicine you cannot buy is misleading you about both.


Frequently asked questions

Is CBD legal for dogs in the UK?

CBD products intended for animals are classed as veterinary medicines by the Veterinary Medicines Directorate and require a marketing authorisation before they can be sold or supplied in the UK. No CBD product has ever received one for veterinary use. There is therefore no legal over-the-counter CBD product for dogs in the UK, and administering an unauthorised CBD product to an animal without a veterinary prescription is an offence under Regulation 8 of the Veterinary Medicines Regulations.

Can my vet prescribe CBD for my dog?

Yes, in principle. Because no authorised veterinary CBD product exists, a vet may prescribe a legally obtained human CBD product under the veterinary prescribing cascade, exercising their own clinical judgement and responsibility. In practice many vets decline, citing the limited canine evidence base and inconsistent product quality. That is a legitimate clinical position rather than an administrative obstacle.

Is CBD oil the same as hemp oil for dogs?

No. Hemp seed oil is pressed from hemp seeds, is a source of fatty acids, contains only trace cannabinoids and is a permitted feed material. CBD oil is extracted from the flower and leaf and is formulated to deliver cannabidiol, which UK regulators treat as a medicine. Many dog products marketed around the word hemp contain hemp seed oil and essentially no CBD.

Can I give my dog human CBD oil?

Not without a prescription from your vet. Administering an unauthorised CBD product to an animal without a veterinary prescription is an offence under the Veterinary Medicines Regulations, and companies selling CBD for human use are not permitted to recommend it for animals. There is also a practical hazard: some human CBD products contain xylitol, a sweetener that is severely toxic to dogs.

Does CBD work for dogs with joint pain?

This is where the canine evidence is strongest, though it remains limited. A 2018 randomised placebo-controlled crossover trial at Cornell University found that CBD at 2 mg/kg twice daily significantly reduced owner-scored pain and increased activity in dogs with osteoarthritis over four weeks. The studies are small, short and often industry-funded, so this is a promising early signal rather than an established treatment effect.

Does CBD calm anxious dogs?

The evidence is weak and mixed. A 2020 study using a validated fireworks fear model found no support for an anxiolytic effect at 1.4 mg/kg per day, with no reduction in cortisol or in fearful behaviour. A 2023 study found a single dose did improve stress measures during car travel and separation. The reasonable interpretation is that CBD may help with acute, short-lived stressors and has not been shown to address established noise phobia or chronic anxiety.

What are the side effects of CBD in dogs?

The most consistent finding across canine studies is a rise in serum alkaline phosphatase, a liver enzyme, whose long-term significance is not yet established. Ataxia, meaning wobbliness and loss of coordination, has caused dogs to be withdrawn from trials. Gastrointestinal upset including vomiting and diarrhoea is reported, generally at higher doses.

Is CBD safe to give alongside my dog's other medication?

This needs a veterinary conversation rather than a general answer. CBD inhibits cytochrome P450 enzymes, which the liver uses to metabolise a wide range of drugs, so it can alter how other medications behave. One canine study found CBD appeared to blunt the effect of trazodone, consistent with interference in its metabolism. If your dog takes any regular medication, do not add CBD without your vet's involvement.

The bottom line

CBD for dogs in the UK is not a grey area in law, however grey the marketplace looks. It is a veterinary medicine, no product is licensed, and the only lawful route runs through your own vet. The science, meanwhile, is genuinely interesting on joint comfort, thin and contradictory on anxiety, and frequently overstated everywhere. Both of those things can be true at once, and an owner is better served knowing both than being sold either half on its own.

This article is for general information and does not constitute veterinary advice. If your dog is unwell, in pain, or you are considering any change to their treatment, speak to your own vet, who knows your dog's history.

References

Veterinary Medicines Directorate (2018). VMD statement on veterinary medicinal products containing Cannabidiol. GOV.UK, published 14 September 2018.

The Veterinary Medicines Regulations 2013 (SI 2013/2033), Regulation 8 and Schedule 4 (the prescribing cascade).

Gamble L-J, Boesch JM, Frye CW, Schwark WS, Mann S, Wolfe L, Brown H, Berthelsen ES, Wakshlag JJ (2018). Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Frontiers in Veterinary Science, 5:165. doi:10.3389/fvets.2018.00165

Mejia S, Duerr FM, Griffenhagen G, McGrath S (2021). Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs. Journal of the American Animal Hospital Association, 57(2):81-90. doi:10.5326/JAAHA-MS-7119

Morris EM, Kitts-Morgan SE, Spangler DM, McLeod KR, Costa JHC, Harmon DL (2020). The Impact of Feeding Cannabidiol (CBD) Containing Treats on Canine Response to a Noise-Induced Fear Response Test. Frontiers in Veterinary Science, 7:569565. doi:10.3389/fvets.2020.569565

Hunt ABG, Flint HE, Logan DW, King T (2023). A single dose of cannabidiol (CBD) positively influences measures of stress in dogs during separation and car travel. Frontiers in Veterinary Science, 10:1112604. doi:10.3389/fvets.2023.1112604

McGrath S, Bartner LR, Rao S, Packer RA, Gustafson DL (2019). Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. Journal of the American Veterinary Medical Association, 254(11):1301-1308. doi:10.2460/javma.254.11.1301

Corsato Alvarenga I, Panickar KS, Hess H, McGrath S (2023). Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases. Annual Review of Animal Biosciences, 11:227-246. doi:10.1146/annurev-animal-081122-070236

RCVS Knowledge (2023). The use of cannabidiol (CBD) in animals: evidence collection on the regulatory framework.

 

Back to blog